Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001949846-25-000701
Filing Date
2025-12-18
Accepted
2025-12-18 11:17:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2893
  Complete submission text file 0001949846-25-000701.txt   4671
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-32157 | Film No.: 251581870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address HALOZYME THERAPEUTICS, INC. 11588 SORRENTO VALLEY ROAD, #17 SAN DIEGO CA 92121
Business Address
RAMSAY DAVID A (Reporting) CIK: 0001283292 (see all company filings)

Type: 144